| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 04/21/2004 | CN1490015A Thevina drops and preparation thereof |
| 04/21/2004 | CN1490013A Health products |
| 04/21/2004 | CN1490008A Minlpress hydrochloride drops and preparation thereof |
| 04/21/2004 | CN1490002A Enalapril drops and preparation thereof |
| 04/21/2004 | CN1490000A Hippophae rhamnoide flavone drops and preparation thereof |
| 04/21/2004 | CN1489999A Use of tanshinone in therapeutic medicines for abnormal hyperplasia of vascular smooth muscle cells |
| 04/21/2004 | CN1489998A Isosorbide dinitrate drops and preparation thereof |
| 04/21/2004 | CN1146557C Process for prepn. of 1-type sodium-hydrogen exchange agent inhibitor |
| 04/21/2004 | CN1146556C 1,2-dihydroindene or indoline derivatives, preparation and use thereof |
| 04/21/2004 | CN1146545C Benzoylpyridazines |
| 04/21/2004 | CN1146543C Serine protease inhibitor |
| 04/21/2004 | CN1146542C Benzamide derivatives and their use as cytokine inhibitors |
| 04/21/2004 | CN1146541C Beta-alanine derivatives |
| 04/21/2004 | CN1146538C Process for preparation of zofenopril calcium salt |
| 04/21/2004 | CN1146537C Dofetilide polymorphs |
| 04/21/2004 | CN1146455C 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 04/21/2004 | CN1146440C Vascular endothelial growth factor-B |
| 04/21/2004 | CN1146433C Hemorrhoidal powder |
| 04/21/2004 | CN1146429C Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agent |
| 04/21/2004 | CN1146418C Fixed-dose association of angiotensin-converting enzyme inhibitor and of calcium channel antagonist, method for preparation and use thereof in treatment of cardivas cular illnesses |
| 04/20/2004 | US6723841 Corticotropin-releasing factor2 receptors |
| 04/20/2004 | US6723830 Short peptides which selectively modulate the activity of protein kinases |
| 04/20/2004 | US6723751 Individual polymorphic forms of crystalline sodium salt having specified x-ray diffraction spectra |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723744 Indole carboxylic acids as thyroid receptor ligands |
| 04/20/2004 | US6723741 Benzimidazoles and benzothiazoles and uses thereof |
| 04/20/2004 | US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides |
| 04/20/2004 | US6723736 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (tnf-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (cox-2) |
| 04/20/2004 | US6723733 Polymerase inhibitor |
| 04/20/2004 | US6723723 Heterocyclic derivatives as inhibitors of factor Xa |
| 04/20/2004 | US6723722 Acylhydrazine derivatives, their production and use |
| 04/20/2004 | US6723721 CRF receptor antagonists and methods relating thereto |
| 04/20/2004 | US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents |
| 04/20/2004 | US6723718 Substituted α, β-anellated butyrolactones |
| 04/20/2004 | US6723694 Short peptides which selectively modulate intracellular signalling |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723525 Methods and compositions for screening modulators of lipid kinases |
| 04/20/2004 | US6723522 For use as an antibody, in expression systems, for measuring activity of the cotransporter, in drug screening and design, or as a reagent for making a probe or a pcr primer, making transgenic animal |
| 04/20/2004 | US6723350 Powder of one or more antimicrobial metals formed with atomic disorder; coating becomes antimicrobial and anti-inflammatory when wet. |
| 04/20/2004 | US6723344 Useful as implantable devices and wound dressings as the matrix of the invention is designed to be used in conjunction with such devices to provide protracted and controlled release of growth factor, to promote wound healing |
| 04/20/2004 | US6723343 Pharmaceutical tramadol salts |
| 04/20/2004 | US6723327 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 04/20/2004 | US6723322 Angiogenic Onchocerca volvulus proteins and uses thereof |
| 04/20/2004 | CA2310136C Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 04/20/2004 | CA2246485C Novel derivatives of indole and indazole, process for their preparation and pharmaceutical compositions containing them |
| 04/15/2004 | WO2004031203A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 04/15/2004 | WO2004031187A1 Pyridine-substituted pyrazolopyridine derivative |
| 04/15/2004 | WO2004031177A1 2-aminobenzimidazole derivative |
| 04/15/2004 | WO2004031171A1 Isoquinoline compounds and medicinal use thereof |
| 04/15/2004 | WO2004031166A1 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof |
| 04/15/2004 | WO2004031116A1 Novel substituted arylhexadienoic acids and esters thereof which can be used for the treatment and prevention of diabetes, dyslipidaemia and atherosclerosis, pharmaceutical compositions comprising them and processes for the preparation of them |
| 04/15/2004 | WO2004030698A1 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 04/15/2004 | WO2004030691A1 Sustained release preparation containing nk4 |
| 04/15/2004 | WO2004030690A1 THERAPEUTIC USES OF β-CASEIN A2 AND DIETARY SUPPLEMENT CONTAINING β-CASEIN A2 |
| 04/15/2004 | WO2004030689A1 Composition containing eosinophil cationic protein |
| 04/15/2004 | WO2004030607A2 Peptide-based passive immunization therapy for treatment of atherosclerosis |
| 04/15/2004 | WO2004030448A1 RELATIONSHIP BETWEEN LIPOPROTEIN (a) AND ATHEROMA SCLEROSIS |
| 04/15/2004 | WO2004018436A3 Compounds derived from aryl carbamates, preparation thereof and uses of same |
| 04/15/2004 | WO2004014859A3 Process for preparing quinolin antibiotic intermediates |
| 04/15/2004 | WO2004010987A3 Use of s1p receptor agonists in heart diseases |
| 04/15/2004 | WO2004006850A3 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 04/15/2004 | WO2004005309A3 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/15/2004 | WO2004005262A3 New neuropeptide y y5 receptor antagonists |
| 04/15/2004 | WO2004004689A8 Compositions and methods for amelioration of human female sexual dysfunction |
| 04/15/2004 | WO2004002509A3 Use of casein peptides for treating hypertension |
| 04/15/2004 | WO2004002477A8 2-(phenyl)-2h-pyrazole-3-carboxylic acid-n-4-(thioxo-heterocyclyl)-phenyl-amide derivatives and corresponding imino-heterocyclyl derivatives and relates compounds for use as inhibitors of the coagulation factors xa and/or viia for treating thromboses |
| 04/15/2004 | WO2003106381A3 Human adam-10 inhibitors |
| 04/15/2004 | WO2003102579A3 Method of screening groups of radioactive molecules and applications thereof |
| 04/15/2004 | WO2003091266A3 Protein stabilisation using chaperone proteins |
| 04/15/2004 | WO2003088956A8 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide |
| 04/15/2004 | WO2003082893A3 Theraputic methods and uses of sapogenins and their derivatives |
| 04/15/2004 | WO2003056899A9 Nitric oxide donors for treatment of disease and injury |
| 04/15/2004 | WO2003053359A3 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| 04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/15/2004 | WO2003006057A8 Composition and method for the treatment of disease |
| 04/15/2004 | WO2002083111A3 Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence |
| 04/15/2004 | WO2002081703A9 Mitogenic oxygenase regulators |
| 04/15/2004 | WO2002069980A3 Pharmaceutically effective ginsenosides and their use |
| 04/15/2004 | WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods |
| 04/15/2004 | WO2002060389A3 Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same |
| 04/15/2004 | WO2002050090A8 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 04/15/2004 | WO2002000611A9 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/15/2004 | WO2001092479A8 Method to determine the differentiation potential of a target cell |
| 04/15/2004 | US20040073958 Transgenic animal having drug metabolism enzyme gene and utilization thereof |
| 04/15/2004 | US20040073190 Methods and devices for treating aneurysms |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073025 Thrombin inhibitors |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040073007 Antiangiogenic peptides |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072881 Dietetics; osteoporosis; muscular disorders |
| 04/15/2004 | US20040072879 Calcium channel blockers; antiischemic agents; hypotensive agents |
| 04/15/2004 | US20040072878 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072865 Anticholesterol agents; antidiabetic agents; antilipemic agents |
| 04/15/2004 | US20040072862 Compositions for treating ischemia-related neuronal damage |
| 04/15/2004 | US20040072860 Piperazin-2-one amides as inhibitors of factor xa |